Small Cap Losers: USAS, SEEL, CVM
4:35 pm Monday, May 17th, 2021
Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) slumped 24.345 to $1.71. The company reported Q1 results, including revs of $10.2 million and a net loss of $(91.8) million. Co noted that following an extensive review and a challenging ramp-up at Relief Canyon, the operation is proceeding with run-of-mine heap leaching; co is also confident that a resolution will be reached to reopen its Cosalá Operations. At 52-week lows.
Seelos Therapeutics Inc (NASDAQ: SEEL) stock slide 17.82% to $4.26. The company announced top-line data from the open-label cohort of its Proof-of-Concept study of SLS-002; per co, SLS-002 demonstrated significant treatment effect and a well-tolerated safety profile for Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder. SLS-002 demonstrated a 76.5% response rate in the primary endpoint on MADRS 24 hours after the first dose, and a 92.9% response rate was observed in a key secondary endpoint on Day 16. There were no serious adverse events. Four subjects discontinued the trial prior to completion.
CEL-SCI Corporation (NYSEAMERICAN:CVM) is another notable loser in today’s trading session as the stock fell 15.27% to $18.92. A report from Stat News today highlighted doubts surrounding co’s delayed cancer drug Multikine.
